Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/2474| Title: | Where's the bleed? A response to Piccini et al.'s: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial | Authors: | Bamford, Paul ;Rogers, James | Affliation: | Central Coast Local Health District Gosford Hospital |
Issue Date: | 14-May-2019 | Source: | 40(19):1567 | Journal title: | European Heart Journal | Department: | Cardiology | Abstract: | No abstract available | URI: | https://hdl.handle.net/1/2474 | DOI: | 10.1093/eurheartj/ehy739 | Pubmed: | https://pubmed.ncbi.nlm.nih.gov/30476023 | Publicaton type: | Journal Article | Keywords: | Cardiology Drug Therapy |
| Appears in Collections: | Health Service Research |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.